{
    "title": "Smallpox fear fuels Acambis revival",
    "url": "https://www.dailymail.co.uk/money/news/article-1542988/Smallpox-fear-fuels-Acambis-revival.html",
    "date": "2002-03-12",
    "keywords": [
        "year",
        "contract",
        "acambis",
        "vaccine",
        "company",
        "profitability",
        "line",
        "research",
        "fear",
        "revival",
        "money",
        "gmt",
        "march",
        "view",
        "manufacturer",
        "result",
        "government",
        "citizen",
        "value",
        "bioterrorism",
        "impact",
        "group",
        "loss",
        "competition",
        "glaxosmithkline",
        "merck",
        "co",
        "position",
        "biotech",
        "firm",
        "brink",
        "ftse",
        "index",
        "midcap",
        "monday",
        "trump",
        "card",
        "september",
        "center",
        "disease",
        "control",
        "prevention",
        "country",
        "turnover",
        "cash",
        "december",
        "development",
        "spending",
        "cost",
        "manufacturing",
        "plant",
        "bottom",
        "peptide",
        "birmingham",
        "university",
        "windfall",
        "pipeline",
        "product",
        "fever",
        "approval",
        "food",
        "drug",
        "administration",
        "half"
    ],
    "category": [
        "money",
        "news"
    ]
}